Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103087033B reveals a catalyst-free route to oxepin-3(2H)-ones. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolone intermediates, offering significant cost reduction in API manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles offers high yield and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN115353511A details a safe, multi-component synthesis of indolinone-imidazole derivatives using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN109678840B reveals normal pressure hydrogenation for high-purity pomalidomide. Reduces equipment costs and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN115286635A details a metal-free asymmetric synthesis of chiral pyrazolones with high ee. Offers cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112920066A reveals a novel palladium-catalyzed route for alpha-amino acid esters, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108530240B details a mild one-pot synthesis of aryl trifluoromethoxy compounds from arylamines, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Advanced HDDA reaction pathway for complex naphthalene derivatives offering high atom economy and scalable production for pharmaceutical and agrochemical applications.
Patent CN102924362B reveals green synthesis for Gliclazide intermediate. Offers high purity, reduced waste, and scalable surfactant systems for reliable supply chains.
Patent CN104086456A details a green Suzuki coupling method for sartanbiphenyl, offering cost reduction in API intermediate manufacturing and enhanced supply chain reliability.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel Pd-catalyzed synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN117304094A reveals visible-light method for high-purity 3-trifluoromethylpyridine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel palladium-catalyzed carbonylation method for indolo isoquinoline compounds offers efficient synthesis and supply chain advantages for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed route for quinolinone derivatives offers high yields and broad functional group tolerance for pharmaceutical intermediates.
Patent CN110183378A reveals high-yield catalytic route for nicotinamide derivatives ensuring supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN113045489B details a novel Pd-catalyzed carbonylation route using benzisoxazole, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel DMF-based synthesis of 3-CF3-1,2,4-triazoles disclosed in CN114920707B. Cost-effective, scalable route for API intermediates without anhydrous conditions.